Chase AIBulk Dataset ExportPricingFAQsBlog
Display currency
Loading news…

Cornerstone Therapeutics

ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).
Cary, North Carolina, United States Founded 2000 51-100 employees For Profit

Cornerstone Therapeutics is a pharmaceutical company focused on developing and commercializing products for the respiratory system.

Cornerstone Therapeutics on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.

Cornerstone Therapeutics was acquired by Chiesi Farmaceutici in 2014.
Total Funding
$30M
Funding Rounds
1
Last Funding
Acquisitions
3
Monthly Visits
Contacts
0

About Cornerstone Therapeutics

Funding & Financials

Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Delisted
Ticker
CRTX
Exchange
NASDAQ
IPO date
May 27, 2004
Raised at IPO
$42M
Valuation at IPO
$167.3M
Delisted
Feb 4, 2014

Web Traffic

Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
4
Active products
5
IT spend
$8.82M

Company Info

Founded
2000
Employees
51-100
Operating status
Closed
Company type
For Profit
Org types
company
Founders
2
Sub-organizations
1
News articles
4
HQ
Cary, North Carolina, United States
Region
Research Triangle, East Coast, Southern US
Exit date
May 27, 2004
Closed
Feb 4, 2014

Signals & Scores

Heat score
Low
Trend (7d)
-0.2
Trend (30d)
4.7
Trend (90d)
5.5

Cornerstone Therapeutics Funding Rounds

1 results
Upgrade to Pro to view this datasetUpgrade
Organization NameFunding TypeLead Investor NamesInvestor NamesFunding StageOrg IndustriesOrg Hq CityOrg Hq CountryOrg DescriptionOrg Number Of EmployeesOrg Website
1–1 of 1Show
Page 1 / 1

Cornerstone Therapeutics Acquisitions

3 results
Acquiree NameAcquirer NameAcquisition TypeAcquisition TermsAcquiree IndustriesAcquiree Hq CityAcquiree Hq CountryAcquiree DescriptionAcquiree Number Of EmployeesAcquirer IndustriesAcquirer Hq CountryAcquirer Number Of EmployeesAcquirer Ipo StatusAcquiree Website
EKR Therapeutics$150M2012-05-15Cornerstone TherapeuticsMergerCashBiotechnologyHealth CarePharmaceuticalTherapeuticsBedminsterUnited StatesEKR Therapeutics provides a segment of the healthcare marketBiotechnologyHealth CareTherapeuticsUnited States51-100Delisted3www.ekrtx.com
Cardiokine2012-01-04Cornerstone TherapeuticsAcquisitionBiotechnologyHealth CarePharmaceuticalPhiladelphiaUnited StatesCardiokine, Inc., a specialty pharmaceutical company, engageBiotechnologyHealth CareTherapeuticsUnited States51-100Delisted3www.cardiokine.com
Critical Therapeutics,Inc.2008-05-02Cornerstone TherapeuticsMergerBiopharmaBiotechnologyClinical TrialsHealth CarePharmaceuticalTherapeuticsLexingtonUnited StatesCritical Therapeutics, Inc. is a privately held biopharmaceuBiotechnologyHealth CareTherapeuticsUnited States51-100Delisted3www.criticaltherapeutics.com
1–3 of 3Show
Page 1 / 1

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions
Bulk Dataset Export

Need the data in bulk? Buy the entire dataset.

5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools

Delivered as CSV, JSON or Parquet — at startup-friendly pricing.

See bulk export

Recent News related to Cornerstone Therapeutics

Loading news…

FAQs about Cornerstone Therapeutics

People who checked this page also checked these

Sectors Cornerstone Therapeutics invests & acquires in

M&A by year

Browse the full Acquirezy directory.